Docusign (NASDAQ:DOCU – Get Free Report) will likely be issuing its Q4 2026 results after the market closes on Tuesday, March 17th. Analysts expect the company to announce earnings of $0.95 per share and revenue of $828.2250 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q4 2026 earning overview page for the latest details on the call scheduled for Tuesday, March 17, 2026 at 5:00 PM ET.
Docusign Price Performance
Shares of DOCU stock opened at $48.69 on Tuesday. The stock has a market capitalization of $9.75 billion, a price-to-earnings ratio of 34.05, a PEG ratio of 2.12 and a beta of 1.03. The company’s fifty day simple moving average is $53.42 and its two-hundred day simple moving average is $65.61. Docusign has a 1 year low of $40.16 and a 1 year high of $94.67.
Insider Activity
In other news, CFO Blake Jeffrey Grayson sold 9,515 shares of the business’s stock in a transaction dated Wednesday, December 17th. The stock was sold at an average price of $68.33, for a total value of $650,159.95. Following the completion of the sale, the chief financial officer owned 118,213 shares of the company’s stock, valued at approximately $8,077,494.29. The trade was a 7.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider James P. Shaughnessy sold 12,000 shares of Docusign stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $67.03, for a total value of $804,360.00. Following the completion of the transaction, the insider directly owned 54,550 shares in the company, valued at $3,656,486.50. This trade represents a 18.03% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 77,476 shares of company stock valued at $5,302,678. Company insiders own 1.66% of the company’s stock.
Institutional Investors Weigh In On Docusign
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on DOCU shares. UBS Group decreased their price target on Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a research report on Friday, December 5th. Weiss Ratings reissued a “hold (c)” rating on shares of Docusign in a research note on Wednesday, January 21st. Robert W. Baird lowered their price target on Docusign from $90.00 to $75.00 and set a “neutral” rating on the stock in a report on Friday, December 5th. Wedbush lowered their target price on shares of Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a research note on Friday, December 5th. Finally, Evercore decreased their price target on shares of Docusign from $92.00 to $80.00 and set an “in-line” rating on the stock in a report on Friday, December 5th. Five investment analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $78.80.
Read Our Latest Stock Analysis on Docusign
About Docusign
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Further Reading
- Five stocks we like better than Docusign
- Gold Shock Coming March 18?
- Buy this Gold Stock Before May 15th, 2026
- America’s 1776 happening again
- J.P. Morgan is betting on this coin
- Central banks just did something they haven’t done since 1967
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
